Epidemiology of Speed Skating-related Injuries

August 7, 2022 updated by: Hugo Olmedillas Fernandez, University of Oviedo
Speed skating is a sport in which there´s a lack of epidemiological studies. In line with the well-established model of sports injury prevention research proffered by van Mechelen, the first stage in this process is establishing the extent of the problem i.e. injury incidence, severity and burden. Through an online survey filled by semiprofessional athletes, it is posible to obtain all this important information. This way, it will be possible to fulfill a gap in the literature and take action in the near future in order to reduce the prevalence of injuries in this sport.

Study Overview

Status

Completed

Conditions

Detailed Description

A retrospective study will be performed in speed skaters. 100 speed skaters will be recruited. Data of all injury along a whole season will be collected. Patients' information, including age, number of years playing, skill level and injured body part, will be analysed

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Asturias
      • Oviedo, Asturias, Spain, 33006
        • Universidad de Oviedo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Speed skaters competing in the spanish national championship

Description

Inclusion Criteria:

  • Being a speed skater and having competed in the 2018 spanish national championship

Exclusion Criteria:

  • Being unable to understand the questionaire, do not accept on participating in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
1.Injury prevalence
Time Frame: [Time Frame: January 2018-December 2018]
Injury prevalence rates [Injury prevalence rates calculated per 1000 hours of play]
[Time Frame: January 2018-December 2018]

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Injury burden
Time Frame: [Time Frame: January 2018-December 2018]
Days lost per 1000 hours of exposure
[Time Frame: January 2018-December 2018]
Injury prevalence according to occurrence
Time Frame: [Time Frame: January 2018-December 2018]
Number of injuries sustained during training/ Number of injuries sustained during a match (% of all)
[Time Frame: January 2018-December 2018]
Injury prevalence by mechanism of injury
Time Frame: [Time Frame: January 2018-December 2018]
Number of injuries according to the mechanism of injury (Contact (Direct or indirect) or Non-Contact) (% of all)
[Time Frame: January 2018-December 2018]
Injury prevalence according to location
Time Frame: [Time Frame: January 2018-December 2018]
Distribution of injuries according to location of the injury (on the body, % of all)
[Time Frame: January 2018-December 2018]
Injury prevalence according to tissue affected
Time Frame: [Time Frame: January 2018-December 2018]
Description of the distribution of injuries according to the type of the injury (muscle only) (% of all)
[Time Frame: January 2018-December 2018]

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2021

Primary Completion (ACTUAL)

February 1, 2022

Study Completion (ACTUAL)

February 1, 2022

Study Registration Dates

First Submitted

December 14, 2021

First Submitted That Met QC Criteria

December 14, 2021

First Posted (ACTUAL)

January 3, 2022

Study Record Updates

Last Update Posted (ACTUAL)

August 9, 2022

Last Update Submitted That Met QC Criteria

August 7, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UO2021-04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports Injury

Subscribe